Health ❯ Healthcare ❯ Patient Safety

Medication Management

Adverse Effects Recall Procedures Patient Guidance Withdrawal Effects Consultation Practices Consultation with Professionals Hydration Therapeutic Alternatives Prescription Tracking Corticosteroid Therapy Drug Replacement Time-Critical Medications Adverse Reactions Cancer Treatment Antibiotic Misuse Essential Medicines Consultation Guidance Antihistamine Prescribing Practices Consultation with Specialists Monitoring Drug Combinations CBD Consumption Effects Prescription Drugs Antibiotics Parkinson's Disease Treatment Recommendations Heatwave Precautions Sedatives Dosage Errors Chemotherapy Antibiotic Stewardship Prescription Practices Pharmacy Services Elderly Care Dehydration Risks Drug Disposal Discontinuation Risks Community Engagement Dosage Adjustments Consultation with Providers Anticoagulation Therapy Controlled Substances Traceability Issues Safeguarding Driving Under Influence Medication Errors Contamination Consultation with Physicians Consulting Healthcare Providers Responsible Use of Medications Professional Guidance Drug Expiration Stock Availability

Nationwide Recall of 25 mg Chlorthalidone Covers 11,460 Bottles

Manufacturer Inventia pulled specific lots after tests showed the tablets failed dissolution standards, raising concern they may not deliver a full dose.

JAMA Study Finds 1 in 4 Medicare Patients With Dementia Receive Risky CNS-Active Drugs

FDA Class II Recall Targets Generic Vyvanse After Dissolution Failures

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures